We offer FMOC-protected unnatural amino acids for synthesis of peptides for biological
research and pharmaceutical development. By introducing conformational constraints, the
peptides may have one or several of the following features: 1. enhancement of peptide
backbone helicity for better target binding; 2. tunable hydrophobicity for desired cellular
permeability and cytotoxicity; and 3. enhancement of peptide stability against proteolytic
breakdown.
We offer nucleosides with modifications at the pyrimidine or purine base, such as 6-
Thioguanine, 7-Deazaadenine, 7-Deazaguanine, 8-Azidoadenine, 8-Bromoinosine and 8-
Iodoadenine, and at the sugar such as 5'-Azido-5'-deoxythymidine, 2'-Azido-2'-deoxyuridine
and 2'-Azido-2'-deoxy-5-methyl uridine.
Structure | Details |
---|---|
|
Product Name: (S)-2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-2-methylhept-6-enoic acid Order number: 201167 CAS: 288617-73-2 Purity: >=95% Appearance: solid MF: C23H25NO4 MW: 379.456 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |
|
Product Name: (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentenoic acid Order number: 201306 CAS: 288617-71-0 Purity: >=95% Appearance: solid MF: C21H21NO4 MW: 351.402 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |
|
Product Name: (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-4-pentenoic acid Order number: 201307 CAS: 288617-76-5 Purity: >=95% Appearance: solid MF: C21H21NO4 MW: 351.402 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |
|
Product Name: (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-6-heptenoic acid Order number: 201308 CAS: 288617-77-6 Purity: >=95% Appearance: solid MF: C23H25NO4 MW: 379.456 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |
|
Product Name: (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoic acid Order number: 201309 CAS: 288617-75-4 Purity: >=95% Appearance: solid MF: C26H31NO4 MW: 421.537 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |
|
Product Name: (2R)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-methyl-9-decenoic acid Order number: 201310 CAS: 945212-26-0 Purity: >=95% Appearance: solid MF: C26H31NO4 MW: 421.537 MP: n.a. oC Description: The alkenyl side chain of this product, Fmoc-protected and solid-phase amenable, can be tied (stapled) with another adjacent alkenyl side chain pre-existed on the peptide backbone via a ring-closure metathesis process. |